346 related articles for article (PubMed ID: 18437851)
1. Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c.
Decaro N; Desario C; Elia G; Martella V; Mari V; Lavazza A; Nardi M; Buonavoglia C
New Microbiol; 2008 Jan; 31(1):125-30. PubMed ID: 18437851
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
Siedek EM; Schmidt H; Sture GH; Raue R
Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
[TBL] [Abstract][Full Text] [Related]
3. Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant?
Larson LJ; Schultz RD
Vet Ther; 2008; 9(2):94-101. PubMed ID: 18597247
[TBL] [Abstract][Full Text] [Related]
4. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the antigenic relationships among canine parvovirus type 2 variants.
Cavalli A; Martella V; Desario C; Camero M; Bellacicco AL; De Palo P; Decaro N; Elia G; Buonavoglia C
Clin Vaccine Immunol; 2008 Mar; 15(3):534-9. PubMed ID: 18160619
[TBL] [Abstract][Full Text] [Related]
6. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
Larson LJ; Schultz RD
Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c.
Wilson S; Illambas J; Siedek E; Stirling C; Thomas A; Plevová E; Sture G; Salt J
Vaccine; 2014 Sep; 32(42):5420-4. PubMed ID: 25148778
[TBL] [Abstract][Full Text] [Related]
8. Intranasal vaccination of pups in the presence of maternally derived antibodies to canine parvovirus (CPV). Evaluation of minimal immunizing dose.
Buonavoglia C; Cavalli A; Tempesta M; Voight V; Buonavoglia D; Corrente M; Sagazio P
New Microbiol; 1995 Oct; 18(4):371-5. PubMed ID: 8590389
[TBL] [Abstract][Full Text] [Related]
9. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
Larson LJ; Schultz RD
Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterisation and nucleotide sequence analysis of canine parvovirus strains in vaccines in India.
Nandi S; Anbazhagan R; Kumar M
Vet Ital; 2010; 46(1):69-81. PubMed ID: 20391369
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of canine parvovirus (CPV) strains detected in vaccinated puppies in Brazil.
Castro TX; Costa EM; Leite JP; Labarthe NV; Cubel Garcia RC
Res Vet Sci; 2011 Apr; 90(2):336-40. PubMed ID: 20609453
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Challenges in Canine Parvovirus 2c in Vaccine Failure Cases.
Yip HYE; Peaston A; Woolford L; Khuu SJ; Wallace G; Kumar RS; Patel K; Ahani Azari A; Akbarzadeh M; Sharifian M; Amanollahi R; Jafari Jozani R; Khabiri A; Hemmatzadeh F
Viruses; 2020 Sep; 12(9):. PubMed ID: 32899378
[TBL] [Abstract][Full Text] [Related]
13. Antigenic analysis of canine parvovirus strains isolated in Italy.
Buonavoglia D; Cavalli A; Pratelli A; Martella V; Greco G; Tempesta M; Buonavoglia C
New Microbiol; 2000 Jan; 23(1):93-6. PubMed ID: 10946411
[TBL] [Abstract][Full Text] [Related]
14. Molecular typing of canine parvovirus strains circulating from 2008 to 2012 in an organized kennel in India reveals the possibility of vaccination failure.
Mittal M; Chakravarti S; Mohapatra JK; Chug PK; Dubey R; Upmanuyu V; Narwal PS; Kumar A; Churamani CP; Kanwar NS
Infect Genet Evol; 2014 Apr; 23():1-6. PubMed ID: 24486948
[TBL] [Abstract][Full Text] [Related]
15. [Canine parvovirus: recent knowledge of the origin and development of a viral pathogen].
Truyen U
Tierarztl Prax; 1994 Dec; 22(6):579-84. PubMed ID: 7716757
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a canine parvovirus strain isolated from an adult dog.
Cavalli A; Bozzo G; Decaro N; Tinelli A; Aliberti A; Buonavoglia D
New Microbiol; 2001 Jul; 24(3):239-42. PubMed ID: 11497080
[TBL] [Abstract][Full Text] [Related]
17. Antibody levels and protection to canine parvovirus type 2.
Elia G; Cavalli A; Cirone F; Lorusso E; Camero M; Buonavoglia D; Tempesta M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):320-2. PubMed ID: 16316392
[TBL] [Abstract][Full Text] [Related]
18. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
[TBL] [Abstract][Full Text] [Related]
19. Detection of canine parvovirus type 2c by a commercially available in-house rapid test.
Decaro N; Desario C; Beall MJ; Cavalli A; Campolo M; Dimarco AA; Amorisco F; Colaianni ML; Buonavoglia C
Vet J; 2010 Jun; 184(3):373-5. PubMed ID: 19410488
[TBL] [Abstract][Full Text] [Related]
20. New approaches for the molecular characterization of canine parvovirus type 2 strains.
Decaro N; Elia G; Campolo M; Desario C; Lucente MS; Bellacicco AL; Buonavoglia C
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):316-9. PubMed ID: 16316391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
